# Liquidia Corp: filings

LQDA · Nasdaq · CIK 1819576 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lqda.md) · [Financials](/companies/lqda/financials.md) · [Filings](/companies/lqda/filings.md) · [Insiders](/companies/lqda/insiders.md)

## Reports and events: 150 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 387, 8-K 115, 144 45, 10-Q 17, S-8 14, 3 11, SC 13G/A 11, 4/A 8, CORRESP 7, 10-K 6, 425 6, DEF 14A 6, DEFA14A 6, EFFECT 6, UPLOAD 6, S-3 5, SC 13D/A 5, SC 13G 5, SCHEDULE 13G/A 5, ARS 4, 424B2 2, 424B3 2, PRE 14A 2, S-3/A 2, S-4/A 2, 424B4 1, 424B5 1, 5 1, 5/A 1, 8-K12B 1, 8-K12B/A 1, D 1, FWP 1, S-3ASR 1, S-4 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 01:49 ET | [8-K](/filings/0001104659-26-115672.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115672 |
| 2026-09-30 | 21:27 ET | [8-K](/filings/0001104659-26-112420.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-112420 |
| 2026-09-03 | 12:00 ET | [8-K](/filings/0001104659-26-104929.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-104929 |
| 2026-08-12 | 10:45 ET | [10-Q](/filings/0001104659-26-094410.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094410 |
| 2026-08-12 | 10:45 ET | [8-K](/filings/0001104659-26-094411.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-094411 |
| 2026-06-17 | 20:31 ET | [8-K](/filings/0001104659-26-075177.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075177 |
| 2026-06-08 | 20:30 ET | [8-K](/filings/0001104659-26-071407.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071407 |
| 2026-05-11 | 11:00 ET | [10-Q](/filings/0001104659-26-058252.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058252 |
| 2026-05-11 | 10:45 ET | [8-K](/filings/0001104659-26-058234.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-058234 |
| 2026-04-24 | 20:15 ET | [DEF 14A](/filings/0001104659-26-048597.md) | Proxy statement, period 2026-06-16 | 0001104659-26-048597 |
| 2026-03-05 | 12:01 ET | [10-K](/filings/0001104659-26-023804.md) | Annual report, period 2025-12-31 | 0001104659-26-023804 |
| 2026-03-05 | 11:45 ET | [8-K](/filings/0001104659-26-023794.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-023794 |
| 2026-01-09 | 11:30 ET | [8-K](/filings/0001104659-26-002306.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002306 |
| 2025-11-03 | 12:00 ET | [10-Q](/filings/0001104659-25-105215.md) | Quarterly report, period 2025-09-30 | 0001104659-25-105215 |
| 2025-11-03 | 11:46 ET | [8-K](/filings/0001104659-25-105199.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105199 |
| 2025-10-30 | 11:00 ET | [8-K](/filings/0001104659-25-104000.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-104000 |
| 2025-08-12 | 10:45 ET | [10-Q](/filings/0001558370-25-011139.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011139 |
| 2025-08-12 | 10:30 ET | [8-K](/filings/0001104659-25-076412.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076412 |
| 2025-07-01 | 20:15 ET | [8-K](/filings/0001104659-25-064738.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-064738 |
| 2025-06-24 | 23:36 ET | [8-K](/filings/0001104659-25-061835.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061835 |
| 2025-06-18 | 20:32 ET | [8-K](/filings/0001104659-25-060654.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-060654 |
| 2025-06-18 | 20:30 ET | [8-K](/filings/0001104659-25-060649.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-060649 |
| 2025-06-02 | 11:00 ET | [8-K](/filings/0001104659-25-055180.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055180 |
| 2025-05-23 | 20:29 ET | [8-K](/filings/0001104659-25-052454.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052454 |
| 2025-05-12 | 10:02 ET | [8-K](/filings/0001104659-25-046935.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-046935 |
| 2025-05-08 | 11:00 ET | [10-Q](/filings/0001558370-25-006848.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006848 |
| 2025-05-08 | 10:40 ET | [8-K](/filings/0001104659-25-045850.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045850 |
| 2025-05-08 | 10:05 ET | [8-K](/filings/0001558370-25-006838.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-006838 |
| 2025-05-05 | 11:00 ET | [8-K](/filings/0001104659-25-044345.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-044345 |
| 2025-04-25 | 20:15 ET | [DEF 14A](/filings/0001104659-25-039440.md) | Proxy statement, period 2025-06-17 | 0001104659-25-039440 |
| 2025-04-22 | 11:30 ET | [8-K](/filings/0001104659-25-037137.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-037137 |
| 2025-03-28 | 20:30 ET | [8-K](/filings/0001104659-25-029401.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-029401 |
| 2025-03-19 | 10:45 ET | [10-K](/filings/0001558370-25-003237.md) | Annual report, period 2024-12-31 | 0001558370-25-003237 |
| 2025-03-19 | 10:38 ET | [8-K](/filings/0001104659-25-025326.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-025326 |
| 2025-03-18 | 12:15 ET | [8-K](/filings/0001104659-25-024784.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-024784 |
| 2025-02-28 | 12:00 ET | [8-K](/filings/0001104659-25-018635.md) | 8.01 Other events | 0001104659-25-018635 |
| 2024-11-26 | 21:58 ET | [8-K](/filings/0001104659-24-123155.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-123155 |
| 2024-11-13 | 12:30 ET | [10-Q](/filings/0001558370-24-015433.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015433 |
| 2024-11-13 | 11:45 ET | [8-K](/filings/0001104659-24-117193.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117193 |
| 2024-10-07 | 20:30 ET | [8-K](/filings/0001104659-24-106685.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-106685 |
| 2024-10-02 | 10:15 ET | [8-K](/filings/0001104659-24-105182.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-105182 |
| 2024-09-17 | 21:15 ET | [8-K](/filings/0001104659-24-100714.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-100714 |
| 2024-09-12 | 20:22 ET | [SC 13D/A](/filings/0000902664-24-005484.md) | Ownership report, active investor, amended | 0000902664-24-005484 |
| 2024-09-12 | 20:01 ET | [8-K](/filings/0001104659-24-099305.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-099305 |
| 2024-09-11 | 12:33 ET | [8-K](/filings/0001104659-24-098792.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-098792 |
| 2024-09-11 | 12:08 ET | [8-K](/filings/0001104659-24-098781.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-098781 |
| 2024-09-04 | 21:51 ET | [SC 13D/A](/filings/0000902664-24-005426.md) | Ownership report, active investor, amended | 0000902664-24-005426 |
| 2024-08-22 | 10:31 ET | [8-K](/filings/0001104659-24-091806.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-091806 |
| 2024-08-19 | 11:00 ET | [8-K](/filings/0001104659-24-090676.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-090676 |
| 2024-08-07 | 11:32 ET | [10-Q](/filings/0001558370-24-011206.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011206 |

Page 1 of 3. [Older](/companies/lqda/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.